STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
96
13F, latest reported quarter
Conversions, 180 days
19
Codes C/M, not in net · no price filed
What the filings say about BXC
Insiders, 180 days
-$2.9M net sold
1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$2.9M
1 notice
BlueLinx insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, BlueLinx Holdings Inc. insiders sold a net $2.9M of stock across 29 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Sep 15, 2021.
No other insider sold within 30 days.
96 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Fennebresque Kim S sold about $2.9M of BXC on Aug 6, 2026, the largest insider sale at the company on our record; 96 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 73.2% of the 4,100 shares held after it.
No other insider bought within 30 days.
96 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, CFO and Treasurer Wall Christopher K bought about $212.4K of BXC on May 20, 2025, the largest insider purchase at the company on our record; 96 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 1,100 shares held after it.
No other insider bought within 30 days.
96 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, CFO and Treasurer Wall Christopher K bought about $76.6K of BXC on May 20, 2025, the largest insider purchase at the company on our record; 96 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BXC planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
KIM FENNEBRESQUE
Filed 2026-08-06
$2.9M
BXC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Acquirers Small and Micro Deep Value ETF
$260.8K position · as of 2026-05-31
1.0%
1290 Essex Small Cap Growth Fund
$1.1M position · as of 2026-07-31
1.0%
Victory Integrity Discovery Fund
$843.1K position · as of 2026-06-30
0.9%
AMG River Road Small Cap Value Fund
$7.4M position · as of 2026-07-31
0.7%
Victory Integrity Small-Cap Value Fund
$5.9M position · as of 2026-06-30
0.5%
NVIT Small Cap Value Fund
$1.0M position · as of 2026-06-30
0.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Shyam Reddy
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$4.7M
$2.3M
$1.2M
+254%
+82%
2022
$3.9M
$4.5M
$2.3M
+143%
+5%
2020
$3.3M
$5.7M
$1.3M
+123%
+26%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.9M sold by insiders over 180 days, 96 funds added last quarter, $2.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.0B
four quarters, 2025-06-29 to 2026-07-04
Revenue, TTM BXC
FY Jan 2026
$3.0B
FY Dec 2024
$3.0B
FY Dec 2023
$3.1B
FY Dec 2022
$4.5B
FY Jan 2022
$4.3B
Jul 2026
$814.1M
Apr 2026
$731.1M
Jan 2026
$715.8M
Sep 2025
$748.9M
Jun 2025
$780.1M
Mar 2025
$709.2M
Dec 2024
$710.6M
Sep 2024
$747.3M
At each fiscal year end
Single quarter
Net margin, TTM
-0.1%
net income over revenue, 2025-06-29 to 2026-07-04
Net margin, TTM BXC
FY Jan 2026
+0.0%
FY Dec 2024
+1.8%
FY Dec 2023
+1.5%
FY Dec 2022
+6.7%
FY Jan 2022
+6.9%
Jul 2026
+0.8%
Apr 2026
-0.2%
Jan 2026
-1.2%
Sep 2025
+0.2%
Jun 2025
+0.6%
Mar 2025
+0.4%
Dec 2024
+0.7%
Sep 2024
+2.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$58.0M
operating cash flow minus capex, 2025-06-29 to 2026-07-04
Free cash flow, TTM BXC
FY Jan 2026
$32.9M
FY Dec 2024
$45.1M
FY Dec 2023
$278.8M
FY Dec 2022
$364.4M
FY Jan 2022
$130.6M
Jul 2026
$8.8M
Apr 2026
-$59.8M
Jan 2026
$56.4M
Sep 2025
$52.7M
Jun 2025
-$36.4M
Mar 2025
-$39.8M
Dec 2024
-$1.5M
Sep 2024
$53.8M
At each fiscal year end
Single quarter
Debt to equity
0.48x
long-term 2026-07-04 plus current 2022-01-01 (54 months older than the period end); equity 2026-07-04
Debt to equity BXC
FY Jan 2026
0.48x
FY Dec 2024
0.46x
FY Dec 2023
0.46x
FY Dec 2022
0.50x
FY Jan 2022
0.80x
Jul 2026
0.48x
Apr 2026
0.48x
Jan 2026
0.48x
Sep 2025
0.48x
Jun 2025
0.48x
Mar 2025
0.46x
Dec 2024
0.46x
Sep 2024
0.45x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.25x
TTM operating cash flow over long-term 2026-07-04 plus current 2022-01-01 (54 months older than the period end)
Cash flow to debt BXC
FY Jan 2026
0.20x
FY Dec 2024
0.29x
FY Dec 2023
1.04x
FY Dec 2022
1.37x
FY Jan 2022
0.50x
Jul 2026
0.25x
Apr 2026
0.12x
Jan 2026
0.20x
Sep 2025
0.06x
Jun 2025
0.07x
Mar 2025
0.28x
Dec 2024
0.29x
Sep 2024
0.48x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-0.3%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on equity BXC
FY Jan 2026
+0.0%
FY Dec 2024
+8.3%
FY Dec 2023
+7.9%
FY Dec 2022
+62.1%
FY Jan 2022
+140.2%
Jul 2026
-0.3%
Apr 2026
-0.6%
Jan 2026
+0.0%
Sep 2025
+2.2%
Jun 2025
+4.5%
Mar 2025
+6.0%
Dec 2024
+8.3%
Sep 2024
+4.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-0.1%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on assets BXC
FY Jan 2026
+0.0%
FY Dec 2024
+3.4%
FY Dec 2023
+3.2%
FY Dec 2022
+21.1%
FY Jan 2022
+25.0%
Jul 2026
-0.1%
Apr 2026
-0.3%
Jan 2026
+0.0%
Sep 2025
+0.9%
Jun 2025
+1.8%
Mar 2025
+2.4%
Dec 2024
+3.4%
Sep 2024
+1.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital BXC
FY Jan 2026
n/a
FY Dec 2024
+15.6%
FY Dec 2023
+16.6%
FY Dec 2022
+57.1%
FY Jan 2022
+71.6%
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Sep 2025
+7.7%
Jun 2025
+9.0%
Mar 2025
+11.0%
Dec 2024
+15.6%
Sep 2024
+12.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+2.6%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-07-04 minus current liabilities
Return on capital employed BXC
FY Jan 2026
+2.4%
FY Dec 2024
+6.6%
FY Dec 2023
+10.7%
FY Dec 2022
+37.3%
FY Jan 2022
+46.3%
Jul 2026
+2.6%
Apr 2026
+2.2%
Jan 2026
+2.4%
Sep 2025
+3.5%
Jun 2025
+4.6%
Mar 2025
+5.2%
Dec 2024
+6.6%
Sep 2024
+7.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing BXC
FY Jan 2026
6,075.00x
FY Dec 2024
16.78x
FY Dec 2023
21.14x
FY Dec 2022
2.31x
FY Jan 2022
3.22x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
6,075.00x
Sep 2025
42.82x
Jun 2025
21.84x
Mar 2025
16.99x
Dec 2024
16.78x
Sep 2024
29.62x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$579.1M
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2026-07-04 plus current 2022-01-01 (54 months older than the period end), minus cash 2026-07-04
Enterprise value BXC
FY Jan 2026
$388.6M
FY Dec 2024
$658.7M
FY Dec 2023
$765.4M
FY Dec 2022
$636.0M
FY Jan 2022
$1.1B
Jul 2026
$421.3M
Apr 2026
$383.4M
Jan 2026
$388.6M
Sep 2025
$451.8M
Jun 2025
$504.7M
Mar 2025
$481.8M
Dec 2024
$658.7M
Sep 2024
$659.9M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.7%
TTM free cash flow over market value at close 2026-10-27
FCF yield BXC
FY Jan 2026
+6.9%
FY Dec 2024
+5.2%
FY Dec 2023
+28.1%
FY Dec 2022
+56.7%
FY Jan 2022
+14.1%
Jul 2026
+13.1%
Apr 2026
+3.2%
Jan 2026
+6.9%
Sep 2025
-4.3%
Jun 2025
-4.0%
Mar 2025
+6.6%
Dec 2024
+5.2%
Sep 2024
+12.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing BXC
FY Jan 2026
n/a
FY Dec 2024
1.10x
FY Dec 2023
n/a
FY Dec 2022
0.67x
FY Jan 2022
0.01x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
1.10x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BXC ranks highest on risk and compliance (63rd percentile) and institutional and government (49th), and lowest on insider conviction (19th), among Wholesale & Retail peers.
Profitability
34
Inputs
Return on equity-0.3% · 32 pct, sector of 206
Return on assets-0.1% · 38 pct, sector of 257
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed+2.6% · 33 pct, sector of 220
Financial health
44
Inputs
Debt to equity0.48x · 41 pct, sector of 222
Cash flow to debt0.25x · 48 pct, sector of 210
Growth
37
Inputs
Revenue growth, YoY+0.0% · 37 pct, sector of 311
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
19
Inputs
Net Form 4 buying (codes P and S), 180d-$2.9M · 38 pct, sector of 187
Insider buyers, 180d0 · 0 pct, sector of 189
Institutional and government
49
Inputs
Funds adding, latest quarter96 · 49 pct, sector of 234
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
63
Inputs
Short interest, % of float+6.6% · 41 pct, sector of 320
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 242
New text in Risk Factors, latest 10-K+10.6% · 48 pct, sector of 226
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BXC filings, in plain words
Are BlueLinx insiders buying or selling BXC?
In the 180 days to 2026-10-28, BlueLinx insiders were net sellers, a net $2.9M across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of BXC?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $2.9M of stock; the latest, by KIM FENNEBRESQUE, was filed 2026-08-06.
Read the full summary
In the 180 days to 2026-10-28, BlueLinx insiders were net sellers of BXC, a net $2.9M across purchases and sales reported on Form 4 by 1 seller. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $2.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.